Fortress Biotech company info

What does Fortress Biotech do?
Fortress Biotech (NASDAQ:FBIO) is a biopharmaceutical company dedicated to acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. The company is especially focused on therapies that can address unmet medical needs across a broad range of disease areas, including oncology, rare diseases, and infectious diseases. Through partnerships and subsidiary companies, Fortress Biotech advances its diversified portfolio, leveraging its expertise to strive for success across different therapeutic fields. The company's objectives revolve around transforming cutting-edge scientific research into groundbreaking treatments, aiming to improve patient outcomes and quality of life.
Fortress Biotech company media
Company Snapshot

Is Fortress Biotech a public or private company?


How many people does Fortress Biotech employ?


What sector is Fortress Biotech in?

pie chart
Health Care

Where is the head office for Fortress Biotech?

location pin
Head Office
Florida, United States

What year was Fortress Biotech founded?

founded flag
Year Founded
What does Fortress Biotech specialise in?
/Biopharmaceutical Development /Novel Therapies /Commercialization Partnerships /Diversified Portfolio /Clinical Research /Acquisition Strategy

What are the products and/or services of Fortress Biotech?

Overview of Fortress Biotech offerings
Cosibelimab, a late-stage, potential best-in-class, anti-PD-L1 monoclonal antibody for metastatic cutaneous squamous cell carcinoma.
MB-107 and MB-207, novel lentiviral gene therapies for X-linked severe combined immunodeficiency.
Avenue Therapeutics, developing intravenous tramadol to manage acute pain in adults.
Triplex, a vaccine in development aimed at preventing cytomegalovirus in stem cell transplant recipients.
BAER-101, an early-stage gene therapy for the treatment of Krabbe disease.

Who is in the executive team of Fortress Biotech?

Fortress Biotech leadership team
  • Dr. Lindsay Allan Rosenwald
    Dr. Lindsay Allan Rosenwald
    Executive Chairman, President & CEO
  • Mr. David  Jin
    Mr. David Jin
    CFO & Head of Corporate Development
  • Mr. Michael S. Weiss Esq.
    Mr. Michael S. Weiss Esq.
    Executive Vice Chairman of Strategic Development & Director
  • Mr. Samuel  Berry
    Mr. Samuel Berry
    General Counsel & Corporate Secretary
  • Dr. George C. Avgerinos
    Dr. George C. Avgerinos
    Senior Vice President of Biologics Operations